NEUE · As filed with the SEC

NeueHealth balance sheet, by quarter

The statement as NeueHealth presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Consolidated Balance Sheets · USD thousands

USD thousands	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023	Q3 2023 Sep 30, 2023
Assets
Current assets:
Cash and cash equivalents	131,618	138,101	83,295	109,839	133,425	112,762	87,299	113,430
Short-term investments	13,946	7,004	9,871	8,842	8,735	0	6,265	156
Accounts receivable, net of allowance of $55 and $27, respectively	53,074	41,716	36,594	43,078	35,926	39,938	39,084	32,663
ACO REACH performance year receivable	—	—	95,075	—	—	—	115,878	—
ACO REACH performance year receivable	321,596	468,346	—	261,215	425,517	646,627	—	350,478
Current assets of discontinued operations	89,804	94,467	173,006	127,638	142,375	149,352	822,570	1,368,694
Current assets of held-for-sale operations (Note 15)	—	—	—	6,108	8,158	—	—	—
Discontinued Operations	—	—	173,006	—	—	—	—	—
Prepaids and other current assets	29,844	38,572	36,807	32,712	31,455	25,786	17,831	46,542
Total current assets	639,882	788,206	434,648	589,432	785,591	974,465	1,088,927	1,911,963
Other assets:
Long-term investments	—	—	—	—	—	—	0	344
Property, equipment and capitalized software, net	11,664	11,108	11,240	11,677	12,028	12,650	14,499	17,517
Goodwill	—	—	—	—	—	—	0	0
Intangible assets, net	66,088	68,576	71,064	73,552	76,040	90,345	93,238	96,150
Long-term assets of discontinued operations (Note 19)	—	—	—	—	—	—	0	0
Other non-current assets	26,055	27,790	27,431	22,122	23,606	27,668	28,816	29,792
Total other assets	103,807	107,474	109,735	107,351	111,674	130,663	136,553	143,803
Total assets	743,689	895,680	544,383	696,783	897,265	1,105,128	1,225,480	2,055,766
Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders’ Equity (Deficit)
Current liabilities:
Medical costs payable	97,837	113,850	124,360	123,665	137,044	157,601	157,903	169,778
Accounts payable	5,317	5,451	6,298	5,898	8,603	6,263	11,841	10,687
Short-term borrowings	1,000	1,000	2,000	0	0	0	303,947	353,947
ACO REACH performance year obligation	248,465	382,478	—	161,855	325,599	529,657	—	224,908
Current liabilities of discontinued operations	—	—	—	—	—	345,048	699,758	974,502
Discontinued Operations	333,799	335,181	344,651	339,576	343,985	—	—	—
Disposal Group, Held-for-Sale, Not Discontinued Operations	—	—	—	4,976	3,981	—	—	—
Risk share payable to deconsolidated entity	—	—	123,981	—	—	—	123,981	—
Warrant liability	—	—	29,738	—	—	—	13,971	—
Risk share payable to deconsolidated entity	123,981	123,981	—	123,981	123,981	123,981	—	—
Warrant liability	27,651	27,089	—	22,252	21,792	11,899	—	9,874
Other current liabilities	70,362	75,022	79,200	90,235	79,222	85,101	79,856	86,806
Total current liabilities	908,412	1,064,052	710,228	872,438	1,044,207	1,259,550	1,391,257	1,830,502
Long-term borrowings	—	—	—	120,252	117,670	66,400	66,400	—
Total long-term borrowings	212,433	207,400	202,614	—	—	—	—	—
Other liabilities	15,899	17,200	17,649	16,616	17,926	21,212	22,441	30,655
Total liabilities	1,136,744	1,288,652	930,491	1,009,306	1,179,803	1,347,162	1,480,098	1,861,157
Redeemable noncontrolling interests	55,729	47,769	48,580	117,876	103,867	98,761	88,908	327,263
Redeemable Series A and B preferred stock	920,417	920,417	920,417	920,417	920,417	920,417	920,417	920,417
Redeemable Series A preferred stock	747,481	747,481	747,481	747,481	747,481	747,481	747,481	747,481
Redeemable Series B preferred stock	172,936	172,936	172,936	172,936	172,936	172,936	172,936	172,936
Shareholders’ equity (deficit):
Common stock, $0.0001 par value; $3,000,000,000 shares authorized in 2025 and 2024; $9,024,240 and $8,320,959 shares issued and outstanding in 2025 and 2024, respectively	1	1	1	1	1	1	1	1
Additional paid-in capital	3,107,121	3,105,109	3,099,423	3,100,990	3,087,570	3,074,654	3,056,027	3,037,946
Accumulated deficit	(4,464,323)	(4,454,268)	(4,442,529)	(4,439,807)	(4,382,393)	(4,323,763)	(4,307,849)	(4,078,133)
Accumulated other comprehensive loss	0	0	0	0	0	(104)	(122)	(885)
Treasury Stock, at cost, $31,526 shares at June 30, 2025, and December 31, 2024, respectively	(12,000)	(12,000)	(12,000)	(12,000)	(12,000)	(12,000)	(12,000)	(12,000)
Total shareholders’ equity (deficit)	(1,369,201)	(1,361,158)	(1,355,105)	(1,350,816)	(1,306,822)	(1,261,212)	(1,263,943)	(1,053,071)
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders’ equity (deficit)	743,689	895,680	544,383	696,783	897,265	1,105,128	1,225,480	2,055,766

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.